383 related articles for article (PubMed ID: 12384361)
1. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
Smith WL; Edlind TD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
Jain P; Akula I; Edlind T
Antimicrob Agents Chemother; 2003 Oct; 47(10):3195-201. PubMed ID: 14506030
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors.
Henry KW; Nickels JT; Edlind TD
Antimicrob Agents Chemother; 2000 Oct; 44(10):2693-700. PubMed ID: 10991846
[TBL] [Abstract][Full Text] [Related]
4. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
Gulat S; Doluca Dereli M
Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
8. The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
Li X; Cai Q; Mei H; Zhou X; Shen Y; Li D; Liu W
J Antimicrob Chemother; 2015 Jul; 70(7):1993-2003. PubMed ID: 25825380
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Barchiesi F; Falconi Di Francesco L; Scalise G
Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
Sanglard D; Ischer F; Monod M; Bille J
Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
Sun LM; Liao K; Liang S; Yu PH; Wang DY
J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
[TBL] [Abstract][Full Text] [Related]
12. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
13. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
Coste AT; Ramsdale M; Ischer F; Sanglard D
Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates.
Marichal P; Gorrens J; Laurijssens L; Vermuyten K; Van Hove C; Le Jeune L; Verhasselt P; Sanglard D; Borgers M; Ramaekers FC; Odds F; Vanden Bossche H
Antimicrob Agents Chemother; 1999 Nov; 43(11):2663-70. PubMed ID: 10543744
[TBL] [Abstract][Full Text] [Related]
15. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
Henry KW; Cruz MC; Katiyar SK; Edlind TD
Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
[TBL] [Abstract][Full Text] [Related]
16. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
17. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
[TBL] [Abstract][Full Text] [Related]
18. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
Onyewu C; Blankenship JR; Del Poeta M; Heitman J
Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
[TBL] [Abstract][Full Text] [Related]
19. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs.
Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y
FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.
Karababa M; Coste AT; Rognon B; Bille J; Sanglard D
Antimicrob Agents Chemother; 2004 Aug; 48(8):3064-79. PubMed ID: 15273122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
